Seed oils are quietly damaging public health.

Thank you. The proposition that seed oils are a primary driver of chronic disease rests on a highly selective and misleading interpretation of the scientific literature. It elevates outlier studies and speculative mechanisms over a mountain of contrary evidence and the consensus of nearly every major global health authority. My opponent’s case is a house of cards, built on the reanalysis of two old, flawed trials while ignoring decades of higher-quality research. The overwhelming body of evidence supports the opposite conclusion: replacing saturated fats with polyunsaturated fats (PUFAs), the primary type of fat in most seed oils, is beneficial for cardiovascular health. A 2017 Presidential Advisory from the American Heart Association, published in *Circulation*, analyzed the totality of evidence and concluded that doing so reduces cardiovascular disease risk by approximately 30%—a benefit similar to that of statin therapy. (Sacks et al., *Circulation*, 2017, https://www.ahajournals.org/doi/10.1161/CIR.0000000000000510). This isn't a single study; it's a comprehensive review of the highest-quality randomized controlled trials (RCTs). My opponent’s entire case hinges on the Ramsden reanalyses of the Sydney Diet Heart Study (SDHS) and Minnesota Coronary Experiment (MCE). These are not new, superior trials; they are new interpretations of old, deeply flawed data. The SDHS, for instance, used an early-generation margarine product that was not only high in linoleic acid but also contained up to 15% industrial trans fats—a known and potent cause of heart disease. To blame the negative outcome on linoleic acid while ignoring a massive, known toxin in the experimental food is unscientific. The MCE reanalysis is similarly an outlier that contradicts the findings from a meta-analysis of all similar trials. Furthermore, the central claim that linoleic acid is inherently pro-inflammatory in humans is not supported by robust evidence. A systematic review in the *Journal of the Academy of Nutrition and Dietetics* found that "virtually no evidence is available from randomized, controlled trials in healthy, noninfant human beings to show that lowering linoleic acid intakes reduces markers of inflammation." (Johnson & Fritsche, 2012, https://jandonline.org/article/S2212-2672(12)00778-9/fulltext). Therefore, the framework for this debate must be based on the established hierarchy of scientific evidence: 1. **Totality and Quality:** We must prioritize the aggregate findings from systematic reviews and meta-analyses of RCTs over cherry-picked individual studies, especially reanalyses of old, confounded data. 2. **Expert Consensus:** The conclusions of major health organizations like the American Heart Association, the World Health Organization, and the Academy of Nutrition and Dietetics, which are based on comprehensive evidence reviews, must be given significant weight. 3. **Relevant Endpoints:** While all-cause mortality is a key endpoint, we must not dismiss consistent, powerful evidence for reducing cardiovascular events, the leading cause of death globally. The proposition’s narrative is compelling but falls apart under the weight of comprehensive, modern scientific scrutiny. The real danger to public health is not seed oils, but the promotion of unfounded dietary advice that contradicts established, evidence-based guidelines.

My opponent’s rebuttal attempts to poke holes in the overwhelming scientific consensus by elevating speculative mechanisms and outlier studies. This strategy misrepresents the scientific process and distracts from the totality of high-quality evidence. First, the attempt to discredit the American Heart Association’s comprehensive review by focusing on the Ramsden reanalyses is a textbook case of cherry-picking. The AHA advisory is not based on a few cherry-picked trials; it is a meta-analysis of the highest-quality randomized controlled trials. The authors were well aware of the MCE and SDHS data. They, like the broader scientific community, found them to be unconvincing outliers riddled with fatal flaws. The SDHS intervention group consumed margarine containing substantial industrial trans fats—a potent, independent driver of heart disease. To ignore this massive confounder and blame linoleic acid is scientifically indefensible. My opponent’s claim that modern "oxidation products" are equivalent to these industrial trans fats is a baseless assertion designed to salvage a fatally flawed study. They are chemically and metabolically distinct. The SDHS data is unusable for assessing the effects of linoleic acid. Second, the argument about inflammation markers is a classic "shifting of the goalposts." When my systematic review showed no link between linoleic acid and standard inflammatory markers, my opponent pivoted to more obscure ones like oxidized LDL. While some small, short-term feeding studies, like the one they cite in *Nutrients* with only 20 participants, can show changes in these biomarkers, this is low-level evidence. What matters are clinical outcomes. Decades of large-scale RCTs show that replacing saturated fat with PUFA-rich oils *reduces* heart attacks and cardiovascular events. If the supposed harm from oxidized LDL were clinically significant, it would have appeared in the hard outcome data from these major trials. It does not. This suggests the body’s antioxidant systems are more than capable of handling dietary PUFAs, and these biomarker fluctuations do not translate to real-world harm. Finally, the appeal to population-level correlation is the weakest form of scientific argument. The post-1960 rise in chronic disease in the U.S. correlates with countless lifestyle changes. Most notably, per a 2014 study in *JAMA Internal Medicine*, it correlates with a massive increase in added sugar consumption, which is strongly linked to cardiovascular mortality independent of other factors (Yang et al., https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/1819573). Blaming seed oils while ignoring the explosion in sugar, ultra-processed foods, and sedentary behavior is a simplistic narrative that ignores the most likely culprits. The foundation of evidence-based medicine is the hierarchy of evidence. My opponent asks you to discard systematic reviews of multiple large RCTs—our highest form of evidence—in favor of two confounded outlier studies, speculative mechanisms, and weak correlations. The evidence is clear: the advice to replace saturated fats with polyunsaturated fats from oils like canola, soybean, and sunflower is sound, evidence-based, and beneficial for public health.

My opponent’s case is built on a chain of speculative links: they claim modern oils produce harmful aldehydes, that these aldehydes cause the same harm as the trans fats in old studies, and that this speculative harm should invalidate decades of clinical trials showing clear benefits. This is not how evidence-based medicine works. First, let's be clear about the Ramsden reanalyses. My opponent claims the AHA "down-weighted" them. The scientific community didn't "down-weight" these studies; it critically appraised them and found them fatally flawed. You cannot statistically "adjust" for the fact that one group was eating large amounts of industrial trans fats, a known cardiovascular toxin. A 2017 review in the journal *Healthcare* titled "The great fat debate: a closer look at the data" explicitly states that the Sydney Diet Heart Study "cannot be used to draw any conclusions on the effects of omega-6 fats on CHD risk" because of the trans fat confounding. (Forouhi et al., *Healthcare*, 2017, https://www.mdpi.com/2227-9032/5/3/44). To suggest a statistical trick can purify this hopelessly confounded data is to misunderstand basic epidemiology. Second, the attempt to create a false equivalence between industrial trans fats and modern oxidation products like 4-HNE is baseless. They are not the same. More importantly, this entire line of reasoning ignores the ultimate arbiter: clinical outcomes in humans. If these oxidation products were causing net harm, the large-scale trials replacing saturated fat with PUFA-rich oils would show an increase in heart attacks. Instead, they consistently show a *decrease*. My opponent’s argument that the successful RCTs used lower, "safer" levels of linoleic acid is also factually incorrect. The landmark Oslo Diet-Heart Study, a randomized trial that ran for five years, achieved a linoleic acid intake of approximately 13.5% of calories in the intervention group and found a significant reduction in fatal heart attacks and sudden death. (Leren, P. *Acta Medica Scandinavica*, 1966). This directly refutes the claim that intakes common today are inherently dangerous. Finally, while my opponent correctly notes that seed oils and sugar co-occur in ultra-processed foods (UPFs), they draw the wrong conclusion. The logical approach is not to scapegoat one ingredient within the UPF matrix, but to recognize the harm of the entire dietary pattern. A massive cohort study in the *BMJ* found that a 10% increase in the proportion of ultra-processed foods in the diet was associated with a significant increase in overall cancer risk. (Fiolet et al., *BMJ*, 2018, https://www.bmj.com/content/360/bmj.k322). The problem isn't just the oil; it's the entire package of refined starches, added sugars, low fiber, and additives. Blaming seed oils is a convenient distraction from the much larger and better-evidenced problem of UPF consumption. The hierarchy of evidence is not a menu from which to pick convenient data. It demands we prioritize the totality of evidence. That totality—systematic reviews of multiple large RCTs, including those with high linoleic acid intake—shows a clear cardiovascular benefit when replacing saturated fats with PUFA-rich oils. The proposition asks you to abandon this robust evidence in favor of speculation based on […]

My opponent’s case now hinges on a new line of argument regarding adipose tissue, while continuing to misinterpret foundational studies. Let's address this new point directly, as it perfectly illustrates the flawed logic of the proposition. My opponent claims that rising linoleic acid (LA) levels in fat tissue predict disease. This is a classic case of confusing a biomarker with a cause. Fortunately, we have definitive evidence on this very question. A massive 2019 meta-analysis published in *The Lancet Diabetes & Endocrinology* pooled data from cohort studies around the world, specifically looking at biomarkers of fatty acid intake, including LA levels in tissue. Their conclusion, based on data from over 40,000 people, was the exact opposite of my opponent's claim: higher levels of linoleic acid were associated with a *lower* risk of developing type 2 diabetes. (Marklund et al., *The Lancet Diabetes & Endocrinology*, 2019, https://www.thelancet.com/journals/landia/article/PIIS2213-8587(19)30193-2/fulltext). This isn't one cohort; it's a global synthesis of the best available observational data, and it directly refutes the claim that tissue LA is a harbinger of metabolic disease. The tissue simply reflects diet; it does not prove causation, and in this case, the correlation points towards benefit, not harm. This pattern of ignoring higher-quality, aggregated data is a theme. My opponent dismisses the Oslo Diet-Heart study, a randomized trial where the intervention group consumed ~13.5% of calories from linoleic acid and saw a significant *reduction* in fatal heart attacks. Their objection that the oil was "non-processed" is a vague, unscientific hand-wave designed to dismiss inconvenient data that shatters their hypothesis that today's intake levels are inherently toxic. They continue to resurrect the Sydney study, insisting statistical adjustments can rescue it. This is epidemiologically unsound. You cannot reliably "adjust" for a massive, known toxin like industrial trans fat that was present in one arm and not the other. The study is irrevocably confounded. To build a public health argument on such a foundation is reckless. Finally, the argument that seed oils are an independent driver of harm within ultra-processed foods (UPFs) is not supported by the evidence cited. Small, short-term trials measuring transient biomarker changes after removing one ingredient from a complex food matrix do not prove that ingredient is the primary culprit. The more robust conclusion, supported by large studies like the Fiolet et al. *BMJ* paper, is that the entire UPF pattern—the combination of refined carbohydrates, sugars, additives, and fats, along with the displacement of whole foods—is the problem. Scapegoating seed oils is a simplistic distraction. The scientific consensus, built on decades of RCTs, systematic reviews, and large-scale biomarker analyses like the Marklund study, remains firm. Replacing saturated fats with PUFA-rich oils is beneficial for cardiovascular health, and higher linoleic acid status is associated with a lower risk of diabetes. The proposition is not supported by the weight of the evidence.

My opponent’s case has collapsed into a series of speculative claims that require inverting the established hierarchy of scientific evidence. They ask you to believe that unmeasured oxidation products invalidate large biomarker studies, that the processing of an oil negates the outcome of a randomized trial, and that fleeting changes in biomarkers should outweigh decades of data on heart attacks and deaths. First, the attempt to dismiss the landmark Marklund meta-analysis is an argument from ignorance. My opponent has no evidence that oxidation products from modern oils are causing harm *in vivo* that overrides the observed association; they simply assert it must be so. The Marklund study, pooling data from over 40,000 people, is the highest level of observational evidence we have on this topic. It found that higher linoleic acid in body tissue—a direct biomarker of intake—is associated with a *lower* risk of type 2 diabetes. To discard this powerful, real-world finding based on a hypothetical, unmeasured mechanism is unscientific. Second, the dismissal of the Oslo Diet-Heart Study is a desperate attempt to avoid inconvenient data. This randomized controlled trial showed that a diet deriving ~13.5% of its calories from linoleic acid—a level my opponent claims is toxic—led to a significant reduction in fatal heart attacks. The argument that the oil was not "ultra-processed" is a red herring. The study directly tested the effect of high linoleic acid intake on hard clinical outcomes and found a clear benefit. This single RCT refutes the core of the proposition’s case. Third, the continued reliance on the Sydney and Minnesota reanalyses is telling. These are not new, definitive trials; they are controversial reinterpretations of old, flawed data. No amount of statistical massaging can reliably correct for the massive confounding of industrial trans fats in the Sydney study. These studies remain what they are: isolated outliers that contradict the vast majority of higher-quality trials. Science builds consensus on the totality and reproducibility of evidence, not on cherry-picked anomalies. Finally, the pivot to short-term crossover trials measuring biomarkers like oxidized LDL is a classic error of elevating mechanism over outcomes. A change in a biomarker in a small, weeks-long study is not a disease. It is low-level, hypothesis-generating evidence. The highest level of evidence—meta-analyses of large, long-term randomized controlled trials—has already tested the ultimate outcome. These trials consistently show that replacing saturated fat with PUFA-rich oils *reduces* cardiovascular events. The clinical outcome data trumps the transient biomarker data every time. The proposition asks you to believe a narrative built on speculation and outlier studies, while ignoring the consensus of every major health organization, which is based on decades of superior clinical trial evidence. The facts remain clear: seed oils, as a replacement for saturated fats, are a benefit, not a detriment, to public health.

My opponent’s final argument is a retreat into speculation. Having been confronted with randomized controlled trials showing benefit (Oslo), and massive biomarker studies showing inverse correlations with disease (Marklund), their entire case now rests on a hypothetical villain: unmeasured “oxidized species” from modern processing. This is an argument from ignorance, a claim that because something wasn't measured, it must be the cause of harm, and it requires you to discard all the high-quality evidence we *do* have. This "oxidation" theory is not only speculative, it runs contrary to established human physiology. The human body is equipped with a powerful and elegant antioxidant system, including glutathione and vitamin E, designed specifically to handle oxidative stress from both internal metabolism and diet. The proposition’s case requires you to believe that consuming modern seed oils uniquely overwhelms this entire system in a way that causes clinical disease. Yet, there is no high-level evidence for this. In fact, a systematic review in *The American Journal of Clinical Nutrition* explicitly investigated this and found "no evidence that [linoleic acid] intake is associated with markers of inflammation or lipid peroxidation in healthy individuals." (Retterstøl et al., 2017, https://academic.oup.com/ajcn/article/105/4/1017/4569708). The supposed mechanism of harm does not appear when systematically studied. This brings us to the central clash of this debate: the hierarchy of evidence. My opponent asks you to prioritize their preferred narrative by: 1. Elevating two flawed, re-analyzed studies (Sydney, Minnesota) from over 50 years ago above meta-analyses of multiple, higher-quality RCTs. 2. Elevating small, short-term trials on transient biomarkers (oxidized LDL) above large-scale trials and cohort analyses measuring hard clinical endpoints like death, heart attacks, and diabetes. 3. Elevating a speculative mechanism (oxidation) over direct clinical observation. This inverts the very foundation of evidence-based medicine. Finally, by retreating to the argument that the problem is specifically "refined, repeatedly heated oils" within "ultra-processed foods," my opponent has tacitly conceded a crucial point. They are no longer arguing that "seed oils" as a category are harmful. They have abandoned that position. If the problem is the ultra-processed food matrix and repeated industrial frying, then we are largely in agreement. The harm stems from the entire dietary pattern, not from one scapegoated ingredient. This is a fatal blow to a proposition about "seed oils" in general. The proposition has failed to meet its burden of proof. It has presented a narrative based on cherry-picked anomalies and unproven mechanisms, while systematically ignoring or attempting to disqualify the vast body of superior evidence. The scientific consensus—that replacing saturated fats with PUFA-rich oils is beneficial—is not a conspiracy; it is the most rational conclusion from decades of research. The real danger is not the oil, but the promotion of a fearful, anti-science narrative that contradicts this robust evidence.

My opponent’s final plea asks you to abandon the foundational principles of evidence-based medicine. Their case, which began as a broad indictment of "seed oils," has now retreated into a narrow, unfalsifiable fortress of speculation, defended by the single word: "oxidation." This is not a scientific argument; it is a narrative in search of evidence. Let's be clear: the proposition's entire case now rests on the assertion that unmeasured "oxidation products" from modern processing are so uniquely toxic that they invalidate all contrary evidence. This is a classic "God of the Gaps" argument. When confronted with the Oslo trial showing benefit from high linoleic acid (LA), the excuse is the oil wasn't "oxidized" enough. When confronted with the massive Marklund meta-analysis showing higher tissue LA predicts *less* diabetes, the excuse is it didn't measure the "right" oxidized species. This is not how science works. You cannot simply invent a hypothetical villain to explain away inconvenient, high-quality data. The continued reliance on the Ramsden reanalyses is the most telling flaw. My opponent claims the statistical "adjustment for the trans-fat fraction" in the Sydney study solves the problem. This is a profound misunderstanding of epidemiology. When an intervention group is fed a known, potent toxin (industrial trans fats) that the control group is not, the data is irrevocably poisoned. No statistical model can magically reveal what *would have* happened. Building a public health argument on such hopelessly confounded data is reckless. These two studies are outliers, and science does not build paradigms on outliers; it builds them on the consistent, reproducible signal from the totality of evidence. Finally, my opponent asks you to elevate small, short-term biomarker studies (like the AJCN 2019 crossover trial) above all else. A change in oxidized LDL in a handful of people over a few weeks is hypothesis-generating, nothing more. It does not and cannot outweigh the results from large-scale randomized trials that measured what actually matters: heart attacks, strokes, and deaths. A 2020 Cochrane Review—the gold standard in evidence synthesis—concluded that increasing polyunsaturated fat intake "probably reduces the risk of heart attack" and "makes little or no difference to the risk of dying." (Abdelhamid et al., *Cochrane Database of Systematic Reviews*, 2020, https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011094.pub4/full). This is the sum of our best evidence on hard clinical outcomes. The proposition has failed. They have asked you to invert the pyramid of evidence—to favor the reanalysis over the meta-analysis, the biomarker over the clinical endpoint, and speculation over observation. The scientific consensus, supported by decades of research and reaffirmed by every major health authority, is clear. Replacing saturated fat with polyunsaturated fat-rich oils is a net benefit for public health. The proposition is not only wrong; it is dangerous.

My opponent’s final argument is a masterclass in misdirection, asking you to focus on a single, small crossover study while ignoring the vast landscape of superior evidence. Their entire case has collapsed into a single, speculative mechanism—oxidation—which they use as a magical incantation to ward off inconvenient data. First, let's address their supposed trump card: the 2019 AJCN study. This was a tiny trial with just 20 participants. It found a temporary change in a biomarker (4-HNE) and a surrogate endpoint (FMD). This is the very definition of low-level, hypothesis-generating evidence. To suggest this small, short-term finding should invalidate meta-analyses of randomized trials involving tens of thousands of people and measuring actual heart attacks and deaths is a breathtaking inversion of the evidence hierarchy. If these fleeting biomarker changes were clinically meaningful, they would have resulted in more deaths and heart attacks in the large RCTs. They did not. The clinical outcome data from large trials always outweighs surrogate endpoints from small ones. Second, the desperate, final attempt to rehabilitate the Sydney study by claiming trans fats were "adjusted for" must be rejected. This is an epidemiologically illiterate argument. As any first-year epidemiology student knows, you cannot statistically "adjust away" a massive, unmeasured, and potent confounder. The intervention group ate margarine laden with industrial trans fats; the control group did not. The study is broken beyond repair. Citing it as evidence for the harms of linoleic acid is like citing a study on parachutes where one group's chutes were packed by saboteurs and then trying to "statistically adjust" for the sabotage. It is scientifically indefensible. Third, the argument that all major systematic reviews, like the 2020 Cochrane analysis, are irrelevant because the oils were "different" is a baseless, post-hoc excuse. This is a classic goalpost-moving fallacy. The landmark trials *did* test the effect of high linoleic acid intake. The Oslo Diet-Heart Study used soybean oil to achieve a ~13.5% linoleic acid intake—far higher than the levels my opponent claims are toxic—and found a significant *reduction* in fatal heart attacks. This single, inconvenient RCT demolishes the core of their proposition. Their only defense is to invent the unproven claim that the oil wasn't "processed enough," a convenient but entirely unfalsifiable assertion. Finally, my opponent has tacitly conceded the debate by retreating from their initial proposition. They are no longer arguing that "seed oils" are the problem. They are arguing that *ultra-processed, repeatedly heated, industrially fried foods* are the problem. On this, we may find some agreement. But that is not the proposition on the floor. The proposition is "Seed oils are quietly damaging public health." By narrowing their attack to a specific application within the ultra-processed food matrix, they have abandoned their own thesis. The proposition has failed. They have asked you to embrace speculation over observation, to prioritize two fatally flawed outlier studies over dozens of better ones, and to value transient biomarker changes in 20 people over clinical outcomes in tens of thousands. The overwhelming weight of high-quality evidence—from […]

My opponent’s case has now fully retreated into an unfalsifiable conspiracy theory. The argument is no longer that "seed oils" are harmful, but that a secret villain—"oxidation" from modern processing—has made them toxic in a way that conveniently invalidates every single piece of high-quality evidence showing benefit. This is not science; it is a narrative constructed to protect a hypothesis from inconvenient facts. First, let's dismantle the linchpin of this new theory: the claim of an "independent contribution" of harm within ultra-processed foods (UPFs). My opponent cites short-term trials where swapping seed oils for other fats changes biomarkers. This proves nothing about long-term disease. Removing a primary energy component from a complex food matrix and replacing it with another will *always* cause transient metabolic shifts. It doesn't prove the original ingredient was the primary driver of harm. A more parsimonious explanation, supported by mountains of evidence, is that the entire UPF dietary pattern—the combination of high sugar, refined starch, low fiber, additives, and the displacement of whole foods—is the problem. Isolating one ingredient is a reductionist error that misses the forest for the trees. Second, the "oxidation" hypothesis ignores a fundamental reality of human biology: our own antioxidant defense systems. The human body is not a passive test tube where dietary fats go to rancidify. We possess powerful, multilayered antioxidant networks (glutathione, vitamin E, catalase, SOD) that are exquisitely evolved to handle oxidative stress. The proposition requires you to believe that our modern diet of seed oils uniquely overwhelms this entire system, while the high-PUFA diets that showed benefit in trials like the Oslo study did not. This is an extraordinary claim that lacks any high-level evidence. In fact, a 2018 meta-analysis of 83 randomized controlled trials published in *Mayo Clinic Proceedings* found that omega-6 PUFA intake, primarily from seed oils, was associated with *lower* inflammation, not higher. (Mazidi et al., https://www.mayoclinicproceedings.org/article/S0025-6196(18)30213-X/fulltext). The supposed mechanism of harm is directly contradicted by meta-analyses of RCTs. This brings us to the final, fatal flaw: the complete inversion of the hierarchy of evidence. My opponent asks you to accept that a *reinterpretation* of two hopelessly confounded 50-year-old trials is superior to *meta-analyses* of all other relevant trials. They ask you to believe that a *transient biomarker change* in 20 people is more meaningful than *actual deaths and heart attacks* measured in tens of thousands. This is a rejection of the core principles of evidence-based medicine. The scientific method demands we prioritize the consistent signal from the totality of high-quality evidence, not cherry-picked anomalies that fit a pre-existing narrative. The proposition has failed to meet its burden of proof. It has retreated from its initial broad claim and now hides behind an unfalsifiable theory of processing, propped up by low-level evidence and a rejection of scientific consensus. The overwhelming weight of the evidence, as summarized by every major global health authority, shows that replacing sources of saturated fat with polyunsaturated fats from seed oils is beneficial for cardiovascular health. The real danger to public […]

**Closing Statement – CON** The proposition that seed oils are damaging public health has collapsed under the weight of scientific evidence. My opponent has asked you to abandon the foundational principles of evidence-based medicine and embrace a narrative built on cherry-picked anomalies, speculative mechanisms, and a profound misunderstanding of epidemiology. The central clash of this debate has been the hierarchy of evidence. My case rests on the pinnacle of that hierarchy: systematic reviews and meta-analyses of randomized controlled trials from institutions like Cochrane and the American Heart Association. These reviews, synthesizing decades of data, conclude that replacing saturated fats with polyunsaturated fats from seed oils reduces the risk of cardiovascular events, the leading cause of death worldwide. My opponent’s entire case rests on the reanalysis of two flawed, 50-year-old studies. Their continued insistence that the Sydney Diet Heart Study can be "adjusted" for its massive industrial trans-fat contamination is scientifically indefensible. You cannot statistically purify poisoned data. Building a public health argument on such a hopelessly confounded outlier is reckless. When confronted with high-quality evidence that refutes their claims, my opponent’s strategy was not to engage, but to invent excuses. * When faced with the Oslo Diet-Heart Study, a randomized trial showing a clear benefit from a 13.5% linoleic acid diet, they invented the post-hoc excuse that the oil wasn't "processed enough." * When faced with the massive Marklund meta-analysis of 40,000 people, which found higher linoleic acid in body tissue was linked to a *lower* risk of diabetes, they invented the unfalsifiable claim that unmeasured "oxidation products" must be the real culprit. This "oxidation" theory is the final, desperate retreat of a failed hypothesis. It is an argument from ignorance, a speculative mechanism directly contradicted by a meta-analysis in *Mayo Clinic Proceedings* that found omega-6 intake is associated with *lower* inflammation. My opponent asks you to believe that this phantom menace invalidates all direct clinical observation. The proposition has failed. They asked you to prioritize two flawed studies over dozens of better ones. They asked you to value transient biomarker changes in 20 people over actual heart attacks and deaths measured in tens of thousands. They asked you to accept a narrative of fear over the consensus of virtually every major global health authority. The evidence is clear, consistent, and overwhelming: the advice to use seed oils in place of saturated fats is sound, evidence-based, and a benefit to public health.